HBPCF (Helix BioPharma) Cyclically Adjusted Book per Share: $0.02 (As of Apr. 2026)


HBPCF Helix BioPharma Corp HBPCF
28 GF Score
Price $1.71
View Full Analysis

What is Helix BioPharma Cyclically Adjusted Book per Share?

Helix BioPharma HBPCF 28 Cyclically Adjusted Book per Share is $0.02 as of Apr. 2026. GuruFocus rates HBPCF with a GF Score™ of 28/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Helix BioPharma's adjusted book value per share for the three months ended in Apr. 2026 was $0.140. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.02 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Helix BioPharma's average Cyclically Adjusted Book Growth Rate was -33.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -50.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -40.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Helix BioPharma was -31.40% per year. The lowest was -50.00% per year. And the median was -33.55% per year.

As of today (2026-06-29), Helix BioPharma's current stock price is $1.71. Helix BioPharma's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 was $0.02. Helix BioPharma's Cyclically Adjusted PB Ratio of today is 85.50.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Helix BioPharma was 76.57. The lowest was 0.00. And the median was 0.00.


Helix BioPharma  (OTCPK:HBPCF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Helix BioPharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.71/0.02
=85.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Helix BioPharma was 76.57. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Helix BioPharma Cyclically Adjusted Book per Share Related Terms


Helix BioPharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Helix BioPharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma Cyclically Adjusted Book per Share Chart

Helix BioPharma Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.13 0.07 0.05 0.01

Helix BioPharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.02 0.02

HBPCF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Helix BioPharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's Cyclically Adjusted PB Ratio falls into.


HBPCF
28GF Score
Helix BioPharma Corp HBPCF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helix BioPharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Helix BioPharma's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book= Book Value per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=0.14/132.2623*132.2623
=0.140

Current CPI (Apr. 2026) = 132.2623.

Helix BioPharma Quarterly Data

Book Value per Share CPI Adj_Book
201607 0.136 101.844 0.177
201610 0.038 102.002 0.049
201701 -0.008 102.318 -0.010
201704 -0.060 103.029 -0.077
201707 -0.001 103.029 -0.001
201710 0.084 103.424 0.107
201801 0.006 104.056 0.008
201804 -0.059 105.320 -0.074
201807 -0.057 106.110 -0.071
201810 -0.061 105.952 -0.076
201901 -0.060 105.557 -0.075
201904 -0.065 107.453 -0.080
201907 -0.113 108.243 -0.138
201910 0.001 107.927 0.001
202001 0.003 108.085 0.004
202004 0.128 107.216 0.158
202007 0.067 108.401 0.082
202010 0.074 108.638 0.090
202101 0.105 109.192 0.127
202104 0.037 110.851 0.044
202107 -0.039 112.431 -0.046
202110 -0.077 113.695 -0.090
202201 -0.113 114.801 -0.130
202204 -0.048 118.357 -0.054
202207 0.007 120.964 0.008
202210 -0.018 121.517 -0.020
202301 0.041 121.596 0.045
202304 0.017 123.571 0.018
202307 -0.015 124.914 -0.016
202310 0.010 125.310 0.011
202401 -0.004 125.072 -0.004
202404 -0.006 126.890 -0.006
202407 -0.001 128.075 -0.001
202410 -0.020 127.838 -0.021
202501 0.000 127.443 0.000
202504 -0.019 129.102 -0.019
202507 0.154 130.287 0.156
202510 0.150 130.603 0.152
202601 0.146 130.366 0.148
202604 0.140 132.262 0.140

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.02 mean?
Helix BioPharma (HBPCF) has a Cyclically Adjusted Book per Share of $0.02 as of Apr. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Helix BioPharma and its competitors.
Is Helix BioPharma's Cyclically Adjusted Book per Share too high?
Helix BioPharma's current Cyclically Adjusted Book per Share is $0.02. Overall, Helix BioPharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Helix BioPharma's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Helix BioPharma's Cyclically Adjusted Book per Share of $0.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Helix BioPharma and its competitors. Helix BioPharma's current Cyclically Adjusted Book per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix BioPharma stock overvalued right now?
Helix BioPharma (HBPCF) has a current Cyclically Adjusted Book per Share of $0.02. The current Cyclically Adjusted Book per Share is $0.02. Helix BioPharma's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Helix BioPharma (HBPCF), the current Cyclically Adjusted Book per Share is $0.02 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix BioPharma Business Description

Other Exchanges HBP0:GermanyHBP:Canada
Address 40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.
28GF Score

Get the complete analysis for HBPCF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71
Price